Skip to main content

Table 1 Clinical pathological parameters of Asian patients with gastrointestinal cancer in this research

From: Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population

Tumor type

Clinical characteristic

 

N (%)

Liver hepatocellular carcinoma (LIHC)

Age (years)

 > 65

36 (22.78)

  

 ≤ 65

122 (77.22)

 

Gender

Male

124 (78.48)

  

Female

34 (21.52)

 

Stage

I–II stage

151 (95.57)

  

III–IV stage

7 (4.43)

 

Vital status

Alive

114 (72.15)

  

Dead

44 (27.85)

Stomach adenocarcinoma (STAD)

Age (years)

 > 65

41 (55.41)

  

 ≤ 65

33 (44.59)

 

Gender

Male

49 (66.22)

  

Female

25 (33.78)

 

Stage

I- II stage

43 (58.11)

  

III–IV stage

29 (39.19)

  

Not reported

2 (2.70)

 

Vital status

Alive

54 (72.97)

  

Dead

19 (25.68)

  

Not reported

1 (1.35)

Esophageal carcinoma (ESCA)

Age (years)

 > 65

6 (15.79)

  

 ≤ 65

32 (84.21)

 

Gender

Male

35 (92.11)

  

Female

3 (7.89)

 

Stage

I–II stage

11 (28.95)

  

III–IV stage

6 (15.79)

  

Not reported

21 (55.26)

 

Vital status

Alive

31 (81.58)

  

Dead

7 (18.42)

Pancreatic adenocarcinoma (PAAD)

Age (years)

 > 65

4 (36.36)

  

 ≤ 65

7 (63.64)

 

Gender

Male

5 (45.45)

  

Female

6 (54.55)

 

Stage

I–II stage

11 (100.00)

  

III–IV stage

0 (0.00)

 

Vital status

Alive

6 (54.55)

  

Dead

5 (45.45)

Colon adenocarcinoma (COAD)

Age (years)

 > 65

2 (18.18)

  

 ≤ 65

9 (81.82)

 

Gender

Male

8 (72.73)

  

Female

3 (27.27)

 

Stage

I–II stage

10 (90.91)

  

III–IV stage

1 (9.09)

 

Vital status

Alive

9 (81.82)

  

Dead

2 (18.18)

Cholangiocarcinoma (CHOL)

Age (years)

 > 65

2 (66.67)

  

 ≤ 65

1 (33.33)

 

Gender

Male

2 (66.67)

  

Female

1 (33.33)

 

Stage

I–II stage

3 (100.00)

  

III–IV stage

0 (0.00)

 

Vital status

Alive

1 (33.33)

  

Dead

2 (66.67)

Rectum adenocarcinoma (READ)

Age (years)

 > 65

0 (0.00)

  

 ≤ 65

1 (100.00)

 

Gender

Male

1 (100.00)

  

Female

0 (0.00)

 

Stage

I–II stage

1 (100.00)

  

III–IV stage

0 (0.00)

 

Vital status

Alive

1 (100.00)

  

Dead

0 (0.00)